BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kuna L, Jakab J, Smolic R, Wu GY, Smolic M. HCV Extrahepatic Manifestations. J Clin Transl Hepatol. 2019;7:172-182. [PMID: 31293918 DOI: 10.14218/jcth.2018.00049] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 El-kassas M, El-folly R, Aboromia M, Aly H, Bahgat M, Hamed M. Effect of achieving sustained virological response with direct-acting antiviral agents on glycemic control in diabetic patients with chronic hepatitis C infection. Egypt Liver Journal 2022;12. [DOI: 10.1186/s43066-022-00190-3] [Reference Citation Analysis]
2 Sekulic S, Mijailovic Z, Petrovic D, Lukic R, Jovanovic M, Jovanovic I. HCV Infection and Chronic Renal Disease. Serbian Journal of Experimental and Clinical Research 2021;0:000010247820210010. [DOI: 10.2478/sjecr-2021-0010] [Reference Citation Analysis]
3 Hinrichsen H. [53/m-Impaired concentration and diffuse arthralgia : Preparation for the medical specialist examination: part 35]. Internist (Berl) 2021;62:261-6. [PMID: 33751137 DOI: 10.1007/s00108-021-00999-x] [Reference Citation Analysis]
4 Roguljic H, Nincevic V, Bojanic K, Kuna L, Smolic R, Vcev A, Primorac D, Vceva A, Wu GY, Smolic M. Impact of DAA Treatment on Cardiovascular Disease Risk in Chronic HCV Infection: An Update. Front Pharmacol 2021;12:678546. [PMID: 34045969 DOI: 10.3389/fphar.2021.678546] [Reference Citation Analysis]
5 Shitole SG, Lazar JM, Hanna DB, Kim RS, Anastos K, Garcia MJ, Tien PC, Lima JAC, Kaplan RC, Kizer JR. HIV, hepatitis C virus and risk of new-onset left ventricular dysfunction in women. AIDS 2021;35:1647-55. [PMID: 33859109 DOI: 10.1097/QAD.0000000000002920] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Zhao Y, Xing H, Wang X, Ou W, Zhao H, Li B, Li Y, Duan Y, Zhuang L, Li W, Cheng D, Quan M, Zhang Y, Ji S. Management of Diabetes Mellitus in Patients with Chronic Liver Diseases. J Diabetes Res 2019;2019:6430486. [PMID: 31915709 DOI: 10.1155/2019/6430486] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
7 Bertino G, Ragusa R, Corsaro LS, Frazzetto E, Messina V, Inguscio L, Lai C, Maglia M, Nunnari A, Caponnetto P. Improvement of health-related quality of life and psychological well-being after HCV eradication with direct-acting antiviral agents. Real life setting data of an Italian cohort valued by Hepatitis Quality of Life Questionnaire (HQLQv2). Health Psychol Res 2020;8:9450. [PMID: 33553794 DOI: 10.4081/hpr.2020.9450] [Reference Citation Analysis]
8 Maslennikov R, Ivashkin V, Efremova I, Shirokova E. Immune disorders and rheumatologic manifestations of viral hepatitis. World J Gastroenterol 2021;27:2073-89. [PMID: 34025065 DOI: 10.3748/wjg.v27.i18.2073] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
9 Zippi M, Toma A, Maccioni F, Pica R. Candida Albicans Lung Abscess in an Illicit Drugs User With Hepatitis C Virus Chronic Infection. Cureus 2021;13:e13117. [PMID: 33728135 DOI: 10.7759/cureus.13117] [Reference Citation Analysis]
10 Cooper CL, Galanakis C, Donelle J, Kwong J, Boyd R, Boucher L, Kendall CE. HCV-infected individuals have higher prevalence of comorbidity and multimorbidity: a retrospective cohort study. BMC Infect Dis 2019;19:712. [PMID: 31438873 DOI: 10.1186/s12879-019-4315-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
11 Schulte B, Schmidt CS, Manthey J, Strada L, Christensen S, Cimander K, Görne H, Khaykin P, Scherbaum N, Walcher S, Mauss S, Schäfer I, Verthein U, Rehm J, Reimer J. Clinical and Patient-Reported Outcomes of Direct-Acting Antivirals for the Treatment of Chronic Hepatitis C Among Patients on Opioid Agonist Treatment: A Real-world Prospective Cohort Study. Open Forum Infect Dis 2020;7:ofaa317. [PMID: 32875003 DOI: 10.1093/ofid/ofaa317] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Shitole SG, Kuniholm MH, Hanna DB, Boucher T, Peng AY, Berardi C, Shah T, Bortnick AE, Christia P, Scheuer J, Kizer JR. Association of human immunodeficiency virus and hepatitis C virus infection with long-term outcomes post-ST segment elevation myocardial infarction in a disadvantaged urban community. Atherosclerosis 2020;311:60-6. [PMID: 32947199 DOI: 10.1016/j.atherosclerosis.2020.08.005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Wang CR, Tsai HW. Human hepatitis viruses-associated cutaneous and systemic vasculitis. World J Gastroenterol 2021; 27(1): 19-36 [PMID: 33505148 DOI: 10.3748/wjg.v27.i1.19] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
14 Zarnegar G, Farhadi A, Seyyedi N, Aboualizadeh F, Ranjbaran R, Farzanfar E, Nejabat N, Behzad-behbahani A. In Vitro Replication of HCV RNA in Peripheral Blood Mononuclear Cells Isolated from Patients Undergoing Treatment for Hepatitis C Virus Infection. Hepat Mon 2020;20. [DOI: 10.5812/hepatmon.108070] [Reference Citation Analysis]